+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Epidemiology and outcome of infections in HIV/HCV-coinfected liver transplant recipients A FIPSE/GESIDA prospective cohort study



Epidemiology and outcome of infections in HIV/HCV-coinfected liver transplant recipients A FIPSE/GESIDA prospective cohort study







Information regarding non-AIDS-related infections in HIV-infected liver recipients is scarce. The aims of this study were to describe the prevalence, clinical characteristics, time of onset, and outcome of bacterial, viral, and fungal infections in HIV/HCV-coinfected OLT recipients and to identify risk factors for developing severe infections. We studied 84 consecutive HIV/HCV-coinfected patients who underwent liver transplantation at 17 sites in Spain between 22 and 26 and followed until December 29. Median age was 42 years and 78% were men. Median follow-up was 2.6 years (IQR, 1.25-3.53) and 54 recipients (64%) developed at least 1 infection. Thirty-eight (45%) patients had bacterial infections, 21 (25%) CMV infection (2 CMV disease), 13 (15%) herpes simplex virus infection, and 16 (19%) fungal infections (7 invasive cases). Nine patients (11%) developed 1 opportunistic infections with 44% mortality. Out of 119 infectious episodes, 43 (36%) occurred in the first month after transplantation and 53 (45%) after the sixth month. Thirty-six patients (43%) had severe infections. Overall, 36 (43%) patients died, and death was related to severe infection in 7 (19%) cases. Severe infections increased mortality almost 3-fold (HR 2.9; 95%CI 1.5-5.8). Independent factors of severe infection included pretransplant MELD score >15 (HR 3.5; 95%CI 1.7-7.1), history of AIDS-defining events prior to transplantation (HR 2.5; 95%CI 1.5-5.1) and non-tacrolimus based immunosuppression (HR 2.5, 95% CI 1.3-4.8). HIV/HCV-coinfected liver recipients had a high rate of severe and opportunistic infections, especially in patients with previous AIDS, a high MELD score, and non tacrolimus-based immunosuppression.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036199646

Download citation: RISBibTeXText

DOI: 10.1002/lt.22431


Related references

Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort study. Liver Transplantation 18(1): 70-81, 2012

Outcome of HCV/HIV-coinfected liver transplant recipients: a prospective and multicenter cohort study. American Journal of Transplantation 12(7): 1866-1876, 2014

Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study. American Journal of Transplantation 18(10): 2513-2522, 2018

Epidemiology of Bloodstream Infections in a Multicenter Retrospective Cohort of Liver Transplant Recipients. Transplantation Direct 2(3): E67, 2016

Infections in liver and lung transplant recipients: a national prospective cohort. European Journal of Clinical Microbiology and Infectious Diseases 37(3): 399-407, 2018

Microbial epidemiology and outcome of bloodstream infections in liver transplant recipients: an analysis of 259 episodes. Liver Transplantation 16(3): 393-401, 2010

Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States. Clinical Infectious Diseases 61(7): 1054-1062, 2016

Infections in Hematopoietic Cell Transplant Recipients: Results From the Organ Transplant Infection Project, a Multicenter, Prospective, Cohort Study. Open Forum Infectious Diseases 4(2): Ofx050, 2017

Epidemiology Of Bacterial Tracheobronchitis In A Prospective Cohort Of Lung Transplant Recipients (Ltrs). Transplantation 82(Suppl 2): 964-965, 2006

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clinical Infectious Diseases 34(7): 909-917, 2002

Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transplant Infectious Disease 12(3): 220-229, 2010

Epidemiology of fungal infections in liver transplant recipients: a six-year study of a large Brazilian liver transplantation centre. Memorias do Instituto Oswaldo Cruz 106(3): 339-345, 2011

Epidemiology and natural history of hepatitis C infections in liver transplant recipients. Journal of Hepatology 22(1 Suppl.): 154-159, 1995

Cytomegalovirus infections in lung and hematopoietic cell transplant recipients in the Organ Transplant Infection Prevention and Detection Study: A multi-year, multicenter prospective cohort study. Transplant Infectious Disease 20(3): E12877, 2018

Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients. Current Opinion in Infectious Diseases 24(4): 333-343, 2011